Status:
COMPLETED
Bupropion SR for Treating Smokeless Tobacco Use
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
West Virginia University
Conditions:
Smokeless Tobacco
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
To determine the efficacy and safety of bupropion SR for quitting tobacco in smokeless tobacco users.
Detailed Description
CONTEXT: No pharmacotherapies have been shown to increase long-term (\≥ 6 month) tobacco abstinence rates among smokeless tobacco (ST) users, although bupropion SR has demonstrated potential eff...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 18 years of age or older
- used ST daily for at least one year
- in good general health
- willing to complete all study procedures
Exclusion
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
End Date :
May 1 2005
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT00414180
Start Date
August 1 2003
End Date
May 1 2005
Last Update
March 14 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905